Aluminum & Magnesium Hydroxides has 11 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Cabotegravir Sodium, Gabapentin, Levothyroxine Sodium. Patients taking Aluminum & Magnesium Hydroxides should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 11
- Moderate
- 9
- Minor
- 2
Moderate (9)
- Aluminum & Magnesium Hydroxides + Cabotegravir Sodium— Decrease cabotegravir concentration; administer antacid products separately.
- Aluminum & Magnesium Hydroxides + Gabapentin— Concomitant use of antacid containing magnesium and aluminum hydroxides reduces gabapentin mean bioavailability by about…
- Aluminum & Magnesium Hydroxides + Levothyroxine Sodium— Antacids may reduce levothyroxine absorption by affecting intragastric pH. Monitor patients appropriately.
- Aluminum & Magnesium Hydroxides + Mycophenilic Acid— Decreases concentrations of MPA; concomitant use is not recommended.
- Aluminum & Magnesium Hydroxides + Mycophenolate Mofetil— Decreases mycophenolic acid (MPA) systemic exposure, which may reduce mycophenolate mofetil efficacy. Administer at leas…
- Aluminum & Magnesium Hydroxides + Quinine— Antacids containing aluminum and/or magnesium may delay or decrease absorption of quinine. Concomitant administration sh…
- Aluminum & Magnesium Hydroxides + Quinine Sulfate— Antacids containing aluminum and/or magnesium may delay or decrease absorption of quinine. Concomitant administration sh…
- Aluminum & Magnesium Hydroxides + Rosuvastatin— Antacids may reduce rosuvastatin absorption. Administer rosuvastatin at least 2 hours before the antacid.
- Aluminum & Magnesium Hydroxides + Rosuvastatin Calcium— Antacids may reduce rosuvastatin absorption. Administer rosuvastatin at least 2 hours before the antacid.
Minor (2)
- Aluminum & Magnesium Hydroxides + Olmesartan Medoxomil— Bioavailability of olmesartan was not significantly altered by co-administration of antacids.
- Aluminum & Magnesium Hydroxides + Tadalafil— Simultaneous administration reduced apparent rate of tadalafil absorption without altering total exposure (AUC).